AL-38022A is a serotonin receptor agonist and psychedelic drug of the indazolethylamine family related to the psychedelic tryptamine 5-MeO-AMT. It is one of a range of similar drugs developed for scientific research and with some possible clinical applications such as in the treatment of glaucoma.Chen HH, May JA, Severns BS. Pyranoindazoles and their use for the treatment of glaucoma. US 6881749 The drug acts as a potent and selective agonist for the 5-HT2 family of serotonin receptors, with highest binding affinity for the 5-HT2C subtype and around four times less affinity for 5-HT2A and 5-HT2B. In drug discrimination tests in animals, it fully substituted for the psychedelic drugs 5-MeO-DMT and DOM. AL-38022A was first described in the scientific literature by Richard Glennon and colleagues in 2009.
See also Indazolethylamine Substituted tryptamine § Related compounds AL-34662 AL-37350A O-Methyl-AL-34662 Ro60-0175 VER-3323 YM-348
References
External links AL-38022A - Isomer Design